from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3339c/icd1

LFCtreatmentdescriptionclass of inhibitor

-1.128

Amikacinug/mL Amikacintranslation

-1.114

Cap5-10ug/mL Capreomycintranslation

-1.113

Rox10-50 ug/mL Roxithromycintranslation

-0.348

SM2-5 ug/mL Streptomycintranslation

-3.371

Tet5-10 ug/mL Tetracyclinetranslation

-0.131

Rif0.2-5ug/mL Rifampicintranscription

0.114

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.825

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.703

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.033

CPZ10-50 ug/mL Chlorpromazinerespiration

0.323

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.245

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.701

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.492

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.946

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.100

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.187

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.018

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.560

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.428

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.472

KCN5-20 ug/mL Potassium cyaniderespiration

-0.214

NaN30.2-2 mM Sodium aziderespiration

-0.183

Nigericin50 uM Nigericinrespiration

0.117

TRC10-150 ug/mL Triclosanrespiration

0.317

TRZ10-25 ug/mL Thioridazinerespiration

-0.773

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.407

menadione6-10 ug/mL Menadionerespiration

0.281

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.195

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.136

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.900

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.750

NRP_1Non-replicating persistence stage 1dosRassociated

-0.065

Amp0.2mg/mL AmpicillincellWall

-0.540

Cephalexin20-100 ug/mL CephalexincellWall

-0.203

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.354

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.270

EMB10-20 ug/mL EthambutolcellWall

0.008

Eta12-40 ug/mL EthionamidecellWall

-0.216

INH0.2-0.4 ug/mL IsoniazidcellWall

0.171

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.401

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.768

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.250

BZA0.12 mg/mL BenzamidearomaticAmides

-0.119

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.240

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.204

H2O24 mM hydrogen peroxideDNAdamaging

-0.345

Levo10 ug/mL LevofloxacinDNAdamaging

-0.640

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.530

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.329

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.085

UVUV-irradiationDNAdamaging

1.306

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.178

Antimycin12.5-50 ug/mL Antimycin A?

-0.206

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.000

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.109

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.587

PA8240.2-2 ug/mL PA-824?

1.987

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.909

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.246

Verapamil50 uM Verapamil?

0.341

mercaptoethanol2 mM 2-Mercaptoethanol?

0.411

methoxatin10-20 ug/mL Methoxatin?